LABORATOIRES GALENIQUES VERNIN : revenue, balance sheet and financial ratios

LABORATOIRES GALENIQUES VERNIN is a French company founded 34 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in DAMMARIE-LES-LYS (77190), this company of category ETI shows in 2024 a revenue of 36.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRES GALENIQUES VERNIN (SIREN 385197736)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 36 326 447 € 37 376 359 € 31 373 634 € 28 597 253 € 28 202 152 € 25 216 146 € 28 255 443 € 29 824 239 € 28 534 039 €
Net income 1 122 509 € 51 110 € 877 013 € -1 555 060 € 624 269 € 281 267 € 969 108 € 1 854 986 € 7 411 887 €
EBITDA -370 207 € 74 405 562 € 580 156 € 365 594 € 930 224 € 861 664 € 1 337 387 € 2 443 755 € 1 829 359 €
Net margin 3.1% 0.1% 2.8% -5.4% 2.2% 1.1% 3.4% 6.2% 26.0%

Revenue and income statement

In 2024, LABORATOIRES GALENIQUES VERNIN achieves revenue of 36.3 M€. Revenue is growing positively over 9 years (CAGR: +3.1%). Slight decline of -3% vs 2023. After deducting consumption (14.9 M€), gross margin stands at 21.4 M€, i.e. a rate of 59%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -370 k€, representing -1.0% of revenue. Warning negative scissor effect: despite revenue change (-3%), EBITDA varies by -100%, reducing margin by 200.1 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.1 M€, i.e. 3.1% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

36 326 447 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

21 418 882 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-370 207 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

875 138 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 122 509 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-1.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 86%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 9.7 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 4.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

86.176%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

39.995%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

4.64%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

9.703

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

38.2%

Solvency indicators evolution
LABORATOIRES GALENIQUES VERNIN

Sector positioning

Debt ratio
86.18 2024
2022
2023
2024
Q1: 0.0
Med: 5.92
Q3: 43.75
Watch +6 pts over 3 years

In 2024, the debt ratio of LABORATOIRES GALENIQUES V... (86.18) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
39.99% 2024
2022
2023
2024
Q1: 28.05%
Med: 51.52%
Q3: 72.2%
Average -12 pts over 3 years

In 2024, the financial autonomy of LABORATOIRES GALENIQUES V... (40.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
9.7 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.01 years
Q3: 1.74 years
Watch

In 2024, the repayment capacity of LABORATOIRES GALENIQUES V... (9.70) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 183.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

183.625

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-167.25

Liquidity indicators evolution
LABORATOIRES GALENIQUES VERNIN

Sector positioning

Liquidity ratio
183.62 2024
2022
2023
2024
Q1: 120.09
Med: 209.86
Q3: 363.93
Average +8 pts over 3 years

In 2024, the liquidity ratio of LABORATOIRES GALENIQUES V... (183.62) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-167.25x 2024
2022
2023
2024
Q1: 0.0x
Med: 1.78x
Q3: 10.15x
Watch -56 pts over 3 years

In 2024, the interest coverage of LABORATOIRES GALENIQUES V... (-167.2x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 80 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 109 days. Favorable situation: supplier credit is longer than customer credit by 29 days. Inventory turnover is 97 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 183 days of revenue, i.e. 18.5 M€ to permanently finance. Over 2016-2024, WCR increased by +93%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

18 471 272 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

80 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

109 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

97 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

183 j

WCR and payment terms evolution
LABORATOIRES GALENIQUES VERNIN

Positioning of LABORATOIRES GALENIQUES VERNIN in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 223 962€ to 688 372€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
223k€ 505k€ 688k€
505 641 € Range: 223 962€ - 688 372€
NAF 5 all-time
How is this estimate calculated?

This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de préparations pharmaceutiques)

Compare LABORATOIRES GALENIQUES VERNIN with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques

Frequently asked questions about LABORATOIRES GALENIQUES VERNIN

What is the revenue of LABORATOIRES GALENIQUES VERNIN ?

The revenue of LABORATOIRES GALENIQUES VERNIN in 2024 is 36.3 M€.

Is LABORATOIRES GALENIQUES VERNIN profitable?

Yes, LABORATOIRES GALENIQUES VERNIN generated a net profit of 1.1 M€ in 2024.

Where is the headquarters of LABORATOIRES GALENIQUES VERNIN ?

The headquarters of LABORATOIRES GALENIQUES VERNIN is located in DAMMARIE-LES-LYS (77190), in the department Seine-et-Marne.

Where to find the tax return of LABORATOIRES GALENIQUES VERNIN ?

The tax return of LABORATOIRES GALENIQUES VERNIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRES GALENIQUES VERNIN operate?

LABORATOIRES GALENIQUES VERNIN operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.